Clinical Trial

A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to assess potential drug-drug interactions of E2086 when coadministered orally with Itraconazole, Carbamazepine, Midazolam, Dextromethorphan, Bupropion, or Combined Oral Contraceptives in Healthy Participants
Trial Details
NCT Number NCT07766369
Lead Sponsor Eisai Inc.
Conditions Healthy Volunteers
Enrollment 93 participants
Start Date 2026-08-12
Primary Completion 2026-11-12 (estimated)
Study Completion 2026-11-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-14